ulixertinib
Showing 1 - 8 of 8
Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2023
Gliomas Trial in Houston (Ulixertinib)
Not yet recruiting
- Gliomas
- Ulixertinib
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2023
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Recruiting
- Tumor, Solid
- +2 more
- Ulixertinib
- Palbociclib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 30, 2022
Tumor, Solid, Gastrointestinal Cancer Trial in San Francisco, Ann Arbor (Ulixertinib, Hydroxychloroquine)
Recruiting
- Tumor, Solid
- Gastrointestinal Cancer
- Ulixertinib
- Hydroxychloroquine
-
Tucson, Arizona
- +7 more
Jan 13, 2023
Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)
Recruiting
- Gastrointestinal Neoplasms
- Ulixertinib
- Hydroxychloroquine
-
Salt Lake City, UtahHuntsman Cancer Institute
Mar 1, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022